Koers Urovant Sciences Ltd.
Aandelen
UROV
BMG9381B1081
Biotechnologie & Medisch Onderzoek
Managers | Titel | Leeftijd | Van |
---|---|---|---|
James Robinson
CEO | Chief Executive Officer | 54 | 01-03-19 |
Ajay Bansal
DFI | Director of Finance/CFO | 62 | 28-10-19 |
Chief Tech/Sci/R&D Officer | 66 | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
James Hindman
BRD | Director/Board Member | 63 | 20-05-20 |
Sef P. Kurstjens
BRD | Director/Board Member | 60 | 01-07-18 |
James Robinson
CEO | Chief Executive Officer | 54 | 01-03-19 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-3,10% | 102 mld. | |
+2,11% | 96,07 mld. | |
-1,80% | 21,66 mld. | |
-17,75% | 20,77 mld. | |
-6,91% | 18,53 mld. | |
-42,00% | 16,91 mld. | |
-28,19% | 13,79 mld. | |
+0,18% | 13,33 mld. | |
+19,90% | 10,94 mld. |